Jonathan brings over 15 years of business development experience working at Ipsen and Servier, including leadership in strategic transactions in the field of microbiota as well as collaborations, licensing, M&A, and alliance management. Previously, he held the role of Chief Operating & Chief Business Development Officer at Somagenetix in Zurich, Switzerland, which is developing gene therapies for rare diseases in immunology, neurology, and oncology.